Ketamine has long been seen as a potential ... It works on the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor in the brain, and is used alongside a newly prescribed oral ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

The inhaled anesthetics affect many receptors (e.g., GABA A, glycine, acetylcholine, serotonin, NMDA) in manners that plausibly could explain anesthesia. Which receptors mediate anesthesia remains ...

MIAMI, FLORIDA / ACCESS Newswire / April 1, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing ...

It’s a strong tranquilliser that’s historically been used as an anaesthetic in hospitals and vets, but recent data suggests that ketamine has become a popular party drug with Gen Z. Latest government ...

The finding that temperature influences how glutamate binds to neuronal receptor proteins to initiate signal transduction reveals the mechanics of one of the brain’s most important processes.

Agents that affect the CNS, including antidepressants and antipsychotics, are often prescribed for patients undergoing surgical procedures. The results of a recent survey conducted at a large ...

Tesla and SpaceX CEO Elon Musk has said that he uses ketamine every other week to manage depression and get out of “a negative state of mind.” But he has clarified that he only uses “a small amount ...